Abstract. A simple high-performance liquid chromatographic method for simultaneous determination of ethylenediaminetetraacetic acid (EDTA), sorbic acid, and diclofenac sodium was developed and validated. Separation was achieved on a C 18 column (10 cm×4.6 mm) using gradient elution. The mobile phase consisted of acetonitrile-ammonium dihydrogen phosphate buffer solution (0.01 M, pH02.5, containing 0.8% tetra-n-butyl ammonium hydroxide). The detector wavelength was set at 254 nm. Under these conditions, separation of three compounds was achieved in less than 10 min. The effect of two metal salts and metal concentration on peak area of EDTA was investigated. The pH effect on retention of EDTA and sorbic acid was studied. The method showed linearity for EDTA, sorbic acid, and diclofenac in the ranges of 2.5-100.0, 5.0-200.0, and 20.0-120.0 μg/mL, respectively. The within-and between-day relative standard deviations ranged from 0.52 to 1.94%, 0.50 to 1.34%, and 0.78 to 1.67% for EDTA, sorbic acid, and diclofenac, respectively. The recovery of EDTA, sorbic acid, and diclofenac from pharmaceutical preparation ranged from 96.0-102.0%, 99.7-101.5%, to 97.0-102.5%, respectively. To the best of our knowledge, this is the first report about simultaneous determination of EDTA, sorbic acid, and diclofenac.
INTRODUCTION
Ethylenediaminetetraacetic acid (EDTA) and edetate salts are used in pharmaceutical formulation, cosmetics, and foods as chelating agents; that is, they form stable watersoluble complexes with alkaline earth and heavy metal ions. The stability of the metal-edetate complex depends on the metal ion involved and on the pH of solution. The calcium chelate is relatively weak and will preferentially chelate heavy metals, such as iron, copper, and lead, with the release of calcium ions. For this reason, edetate calcium disodium (calcium EDTA) is used therapeutically in cases of lead poisoning. Calcium is displaced by heavy metals, such as lead, to form stable EDTA complexes that are excreted in urine.
EDTA and disodium edetate possess some antimicrobial activity but are most frequently used in combination with other antimicrobial preservatives owing to their synergistic effects. Disodium edetate is also used as an anticoagulant since it will chelate calcium and prevent the coagulation of blood in vitro (1) .
Sorbic acid is an antimicrobial preservative (2) with antibacterial and antifungal properties used in pharmaceuticals, foods, enteral preparations, and cosmetics. Generally, it is used at concentrations of 0.05-0.2% in oral and topical pharmaceutical formulations, especially those containing nonionic surfactants. Sorbic acid has limited stability and activity against bacteria and thus is frequently used in combination with other antimicrobial preservatives or glycols, where synergistic effects appear to occur.
Diclofenac sodium [sodium (o-{(2,6-dichlorophenyl) amino}phenyl)acetate] is a synthetic nonsteroidal anti-inflammatory drug widely used in clinical medicine for the treatment of inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis (3, 4) .
The various analytical methods have been proposed for the determination of EDTA (5-9), sorbic acid (10) (11) (12) (13) (14) , and diclofenac sodium (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . To the best of our knowledge, this study is the first report describing simultaneous determination of EDTA, sorbic acid, and diclofenac sodium in pharmaceutical preparations.
Based on this study, a simple chromatographic method for the simultaneous determination of EDTA, sorbic acid, and diclofenac was developed and validated. The method was subsequently used for the determination of EDTA, sorbic acid, and diclofenac sodium in ophthalmic solutions. ammonium hydroxide (20% solution in water), acetonitrile, FeCl 3 ·6H 2 O, and Cu(NO 3 ) 2 ·3H 2 O were obtained from Merck (Darmstadt, Germany). Diclofenac sodium was supplied by EXCELLA (Germany). Deionized water from a Milli-Q system (Millipore, USA) was used for preparation of the buffer and sample solutions. Biofenac Ophthalmic solution (containing 0.1% w/v of diclofenac sodium, 0.1% w/v of disodium EDTA, and 0.2% w/v of sorbic acid) was obtained from the Bakhtar Bioshimi Pharmaceuticals Company (Kermanshah, Iran). Voltaren Ophthalmic (Novartis Pharmaceuticals Corporation, Canada) solution (containing 0.1% w/v of diclofenac sodium, 0.1% w/v of disodium EDTA, and 0.2% w/v of sorbic acid) was obtained from the market.
Apparatus and Conditions
The HPLC system (Waters, USA) which consisted of a binary pump (model 1525) with a Waters UV-vis detector (model 2487) was used. The Chromolith Speed Rod column (RP-C18, 100×4.6 mm) was purchased from Merck (Germany). The mobile phase was acetonitrile-ammonium dihydrogen phosphate buffer solution (0.01 M, pH 02.5, containing 0.8% tetra-n-butyl ammonium hydroxide (Bu 4 NOH) as ionpairing reagent) with gradient elution (Table I ). The mobile phase flow rate was kept constant at 1.0 mL/min. The solutes were detected at 254 nm. The injection volume was 20 μL.
Preparation of Stock and Working Standard Solutions
Working standard solutions containing disodium EDTA and sorbic acid were prepared by dilution of individual aliquots of stock solutions with the diluent (solution of 250 μg/ mL FeCl 3 ·6H 2 O). Two stock solutions were made by dissolving 100 mg of disodium EDTA in 100 mL water and 200 mg of sorbic acid in 100 mL water/methanol (1:1), separately. From these solutions, serial dilutions were made to obtain mixed standard solution with different concentration levels: 2.5, 5.0, 
Preparation of Sample Solutions
Sample solutions were prepared by transferring about 0.5 mL of the ophthalmic solutions (Biofenac and Voltaren Ophthalmic solutions) to a 10-mL volumetric flask and dilution with diluent to obtain a solution containing 50.0 μg/mL diclofenac sodium, 50.0 μg/mL disodium EDTA, and 100.0 μg/ mL sorbic acid.
RESULTS AND DISCUSSION
The goal of this study was to develop a HPLC method for the quantification of EDTA, sorbic acid, and diclofenac ( Fig. 1 ) in pharmaceutical formulations. To save time, simultaneous determination of the three compounds was developed. A typical chromatogram for these compounds is shown in Fig. 2 . It is clear that the proposed method has a superior resolution between the three compounds.
The commonly used methods for EDTA determination by HPLC are based upon the complex formation of EDTA with copper or iron salts. The complexation between EDTA with Fe 3+ leads to the formation of the Fe-EDTA complex that absorbs at 257 nm (32) .
Analysis was performed with pH adjusted to 2.5, with the addition of tetra-n-butyl ammonium hydroxide as ion pair reagent to the mobile phase. Under these conditions, sorbic acid and diclofenac are electrically neutral. The Fe-EDTA complex forms an ion pair with tetra-n-butyl ammonium hydroxide in the mobile phase to become electrically neutral. The use of ion-pairing reagents as mobile phase additives allows the separation of ionic and polar substances on reversed-phase HPLC columns. The increase in hydrophobic character of the ion pair results in a greater a Resolution factor is calculated between each peak and its nearest preceding neighbor (R ¼ 2Δt r = w 1 þ w 2 ) b Tailing factor is calculated at 5% of peak height according to the USP method (T ¼ aþb 2a ; b0distance from the point at peak midpoint to the trailing edge, a0distance from the leading edge of the peak to the midpoint) 
In order to investigate the effect of FeCl 3 ·6H 2 O on the response, 1.0 mL of the EDTA stock solution (1,000 μg/mL) was transferred to a 10-mL volumetric flask and diluted with various concentrations of diluent. The effect of concentration of FeCl 3 ·6H 2 O salt on the peak area of the Fe-EDTA complex in the range of 50.0-350.0 μg/mL is shown in Fig. 3 . As is readily seen from Fig. 3 The influence of mobile phase pH on retention (capacity factor) of the Fe-EDTA complex and sorbic acid on C 18 phase was studied by changing the pH of the mobile phase from 2.0 to 5.5. Figure 4 shows the effect of pH on the capacity factors of the Fe-EDTA complex and sorbic acid. As is obvious, an increase in pH from 2.0 to 5.5 resulted in no large change in the capacity factors of the Fe-EDTA complex and sorbic acid. However, in low pH, the capacity factors of the Fe-EDTA complex and sorbic acid were increased slowly. Therefore, pH 2.5 was selected as the optimum value for further studies.
System Suitability
The purpose of the system suitability test is to ensure that the complete testing system (including instrument, reagents, column, and analyst) is suitable for the intended application. The system suitability was determined by making six replicate injections and analyzing each solute for its peak area, resolution, and peak tailing factor. The system suitability requirements for these compounds were a relative standard deviation (RSD) of less than 1.0, a peak tailing factor of less than 2.0, and a resolution (R s ) greater than 8.0 between adjacent peaks for all analytes. The results are shown in Table II .
Linearity
Linearity is the ability of the test method to provide results that are directly proportional to analyte concentration within a given range. Linearity range using this method for three compounds was wide. Standard curves were plotted using peak area vs. solute concentration. The method was linear from 2.5-100.0, 5.0-200.0, to 20.0-120.0 μg/mL for the Fe-EDTA complex, sorbic acid, and diclofenac, respectively. Each compound had R 2 values of 0.992 or greater. Statistical summaries of linear response for all analytes are shown in Table III .
Precision
Instrumental precision was determined by analyzing test samples by six replicate determinations. RSDs for these determinations were shown in Table II . Within-day precision was calculated by analyzing three standard solutions with different concentration levels for each analyte in the mixture. Between-day precision was performed by analyzing standard solutions in three different days. The results are shown in Table IV .
Accuracy
In order to investigate the presence of matrix effects on the proposed method, a recovery study was carried out. Percent error and recovery of the method were evaluated using spiked samples containing each analyte in different concentration levels. The results shown in Table V indicate that the procedure gives acceptable accuracy and recovery for all analytes in the pharmaceutical preparation.
Assay
The method developed in the present study was applied for the determination of EDTA, sorbic acid, and diclofenac in Biofenac Ophthalmic solution from the Bakhtar Bioshimi Pharmaceutical Company and Voltaren Ophthalmic solution. Figure 5 shows an HPLC chromatogram of the Fe-EDTA complex, sorbic acid, and diclofenac in a pharmaceutical preparation. Results of the assay experiment are exhibited in Table VI .
CONCLUSION
An accurate, sensitive, and reproducible HPLC method for the simultaneous separation and quantitation of EDTA, sorbic acid, and diclofenac in ophthalmic solutions has been developed. This method can be used for routine analysis and quality control of pharmaceutical preparations containing any of these pharmaceutical ingredients.
